Company Profile

Smart Quotes

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla

BSE1473.70-17.2 (-1.15 %)

PREV CLOSE ( ) 1490.90

OPEN PRICE ( ) 1476.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 37074

TODAY'S LOW / HIGH ( )1469.80 1481.85

52 WK LOW / HIGH ( )1310.05 1702

NSE1475.80-15.1 (-1.01 %)

PREV CLOSE( ) 1490.90

OPEN PRICE ( ) 1485.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1475.80 (4080)

VOLUME 1569604

TODAY'S LOW / HIGH( ) 1468.20 1485.00

52 WK LOW / HIGH ( )1335 1702.05

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1935

Management Info

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office

Address Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000

Email contactus@cipla.com

Website www.cipla.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, Luxembourg

NEWS

31May USFDA concludes cGMP inspection at Cip
United States Food and Drugs Administration (USFDA) has concluded curren..

30May Cipla’s arm acquires 26% stake in AMPI
Cipla’s subsidiary -- Jay Precision Pharmaceuticals has completed acquis..

30May Cipla rises as its arm acquires 26% st
Cipla is currently trading at Rs. 1487.25, up by 10.70 points or 0.72% f..

30May Cipla’s arm incorporates new wholly ow
Cipla’s wholly owned subsidiary -- Cipla (EU), UK has incorporated a new..

20May Cipla’s arm inks pact to acquire 26% s
Cipla’s subsidiary -- Jay Precision Pharmaceuticals has entered into Sha..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	14854	51576.5
Gross Profit	17555.5	64688.2
Operating Profit	16120.8	67631.6
Net Sales	47978.9	190448.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

SMS Lifesciences (BSE) 1299.15 (13.58%)	M.Cap ( in Cr)392.77
RPG Life Sciences (BSE) 2645.50 (3.46%)	M.Cap ( in Cr)4375.40
Ajanta Pharma (BSE) 2786.30 (3.18%)	M.Cap ( in Cr)34804.26
Gland Pharma (BSE) 1970.75 (3.94%)	M.Cap ( in Cr)32469.37
NGL Fine-Chem (BSE) 1442.05 (5.00%)	M.Cap ( in Cr)890.90

Shareholding Pattern

	PROMOTERS	29.2%
	MUTUAL FUNDS/UTI	20.51%
	NON-INSTITUTION	16.38%
	FI/BANKS/INSURANCE	5.99%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru Nifty Pharma Index Fund-Reg(G)	10.71
Nippon India Nifty Pharma ETF	10.70
DSP Healthcare Fund-Reg(G)	8.82
Axis NIFTY Healthcare ETF	8.78
Aditya Birla SL Nifty Healthcare ETF	8.78
ICICI Pru Nifty Healthcare ETF	8.77
DSP Nifty Healthcare ETF	8.77